• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenanthrenes and derivatives Phenanthrenes and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenanthrenes and derivatives

Recent Advances in the Study of 1,7-Dimethyl-phenanthrene (CAS: 483-87-4) in Chemical Biology and Pharmaceutical Research

1,7-Dimethyl-phenanthrene (CAS: 483-87-4) is a polycyclic aromatic hydrocarbon (PAH) that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique structural properties, has been the subject of numerous studies aimed at understanding its biological activity, metabolic pathways, and therapeutic potential. The following research briefing synthesizes the latest findings on 1,7-Dimethyl-phenanthrene, focusing on its chemical properties, biological interactions, and emerging applications in drug development.

Recent studies have highlighted the role of 1,7-Dimethyl-phenanthrene as a key intermediate in the synthesis of more complex bioactive molecules. Its structural framework, featuring two methyl groups at the 1 and 7 positions, has been shown to influence its binding affinity to various biological targets, including enzymes and receptors. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that 1,7-Dimethyl-phenanthrene exhibits moderate inhibitory activity against cytochrome P450 enzymes, suggesting its potential as a modulator of drug metabolism. This finding opens new avenues for the development of enzyme inhibitors that could enhance the efficacy of existing therapeutics.

In addition to its enzymatic interactions, 1,7-Dimethyl-phenanthrene has been investigated for its potential anti-inflammatory and anticancer properties. A preclinical study conducted by researchers at the University of Tokyo revealed that this compound could suppress the production of pro-inflammatory cytokines in macrophages, indicating its utility in treating inflammatory diseases. Furthermore, in vitro experiments on cancer cell lines showed that 1,7-Dimethyl-phenanthrene induces apoptosis in certain types of tumor cells, although the exact mechanism remains under investigation. These preliminary results underscore the need for further research to elucidate the compound's full therapeutic potential.

The metabolic fate of 1,7-Dimethyl-phenanthrene has also been a focal point of recent research. A 2022 study published in Chemical Research in Toxicology explored the compound's biotransformation in mammalian systems, identifying several metabolites formed through oxidative processes. These metabolites were found to exhibit varying degrees of biological activity, with some displaying enhanced pharmacological effects compared to the parent compound. Understanding these metabolic pathways is critical for optimizing the design of derivatives with improved pharmacokinetic profiles.

From a synthetic chemistry perspective, advances in the catalytic functionalization of 1,7-Dimethyl-phenanthrene have enabled the development of novel derivatives with tailored properties. For example, a recent breakthrough in palladium-catalyzed C-H activation, reported in Angewandte Chemie, has facilitated the selective modification of the phenanthrene core, yielding compounds with enhanced bioactivity. Such methodologies are paving the way for the creation of libraries of 1,7-Dimethyl-phenanthrene analogs, which could be screened for specific biological targets.

In conclusion, 1,7-Dimethyl-phenanthrene (CAS: 483-87-4) represents a promising scaffold in chemical biology and pharmaceutical research. Its diverse biological activities, coupled with advances in synthetic chemistry, position it as a valuable candidate for further exploration. Future studies should focus on elucidating its mechanisms of action, optimizing its pharmacokinetic properties, and evaluating its safety profile in vivo. As research progresses, this compound may well emerge as a cornerstone in the development of next-generation therapeutics for a range of diseases.

• 581-42-0(2,6-Dimethylnaphthalene)
• 779-02-2(9-Methylanthracene)
• 781-43-1(9,10-Dimethylanthracene)
• 582-16-1(2,7-Dimethylnaphthalene)
• 1576-67-6(3,6-Dimethylphenanthrene)
• 1321-94-4(Methylnaphthalene)
• 2381-21-7(1-Methylpyrene)
• 571-61-9(1,5-Dimethylnaphthalene)
• 28804-88-8(Dimethylnaphthalene, mixture of isomers)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)